Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,316 warrant series at 1,050 companies. 776 in the money, 59 expiring in the next 30 days, 30 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 Pre-Funded Warrants (Private Placement Initial Closing, September 11, 2025) | $3.97 | $249.1M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2026 Pre-Funded Warrants (Private Placement Second Closing, August 3, 2026) | $3.97 | $249.1M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Allianz Warrants | $1.55 | $243.3M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Constellation Warrants – Additional Tranche (May 15, 2024) | $1.55 | $243.3M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Constellation Warrants – Initial Tranche (March 27, 2024) | $1.55 | $243.3M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Acreage replacement warrants (December 2024 Acreage Acquisition) | $0.5361 | $241.4M | 424B5, Aug 29, 2025Dilution tabAs of Nov 9, 2026 | ||||||||
| January 2024 Series A Warrants | $0.5361 | $241.4M | 424B7, Jun 6, 2025Dilution tabAs of Nov 9, 2026 | ||||||||
| January 2024 Series B Warrants | $0.5361 | $241.4M | 424B7, Jun 6, 2025Dilution tabAs of Nov 9, 2026 | ||||||||
| January 2026 Investor Warrants (MMCAP exchange) | $0.5361 | $241.4M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Loan Warrants (January 2026, JGB term loan) | $0.5361 | $241.4M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| May 2024 Investor Warrants (MMCAP) | $0.5361 | $241.4M | 424B7, Jun 6, 2025Dilution tabAs of Nov 9, 2026 | ||||||||
| MTL Replacement Warrants (March 2026 MTL acquisition) | $0.5361 | $241.4M | 10-K, Jun 15, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Put Warrants (Acreage put liability, December 2024) | $0.5361 | $241.4M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| September 2023 Warrants (private placement units) | $0.5361 | $241.4M | 424B7, Jun 6, 2025Dilution tabAs of Nov 9, 2026 | ||||||||
| Series B warrants issued to Stern YOI Ltd. Partnership (August 2020) | $1.21 | $240.3M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 8, 2026 | ||||||||
| Warrants issued to former director Yaron Eitan (September 2020) | $1.21 | $240.3M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 8, 2026 | ||||||||
| Placement Agent Warrants (September 2025 PIPE, R.F. Lafferty) | $0.6229 | $239.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Strategic Advisor Warrants (Worldcoin Tower Warrants) | $0.6229 | $239.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| March 2022 private placement common stock warrants | $0.9481 | $235.7M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| MidCap Warrant (Credit and Security Agreement, December 22, 2021) | $0.9481 | $235.7M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Warrants beneficially owned by Armistice Capital Master Fund Ltd. (series not identified) | $0.9481 | $235.7M | 10-K, Mar 23, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Underwriter warrants – January 2025 underwritten public offering ($8.00, expiring January 29, 2030) | $5.27 | $235.3M | 6-K EX-99.2, Aug 12, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| Underwriter warrants – September 2025 underwritten public offering ($10.00, expiring September 16, 2030) | $5.27 | $235.3M | 6-K EX-99.2, Aug 12, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| February 2023 Investor Warrants | $12.53 | $234.1M | 20-F, Dec 9, 2025Dilution tabAs of Nov 8, 2026 | ||||||||
| February 2023 Placement Agent Warrants | $12.53 | $234.1M | 20-F, Dec 9, 2025Dilution tabAs of Nov 8, 2026 | ||||||||
| September 2023 Investor Warrants | $12.53 | $234.1M | 20-F, Dec 9, 2025Dilution tabAs of Nov 8, 2026 | ||||||||
| September 2023 Placement Agent Warrants | $12.53 | $234.1M | 20-F, Dec 9, 2025Dilution tabAs of Nov 8, 2026 | ||||||||
| Common Stock Warrants (OmniLit public warrants OPTXW and private placement warrants assumed in the Merger), $11.50 exercise price | $5.72 | $231.0M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| 2025 PIPE Warrants | $1.11 | $230.6M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| 2026 PIPE Warrants | $1.11 | $230.6M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Assumed Kodiak Warrants | $1.11 | $230.6M | S-1, May 29, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| NRA Warrants | $1.11 | $230.6M | S-1, May 29, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Private Placement Warrants | $1.11 | $230.6M | S-1, May 29, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Public Warrants (KDKRW) | $1.11 | $230.6M | S-1, May 29, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Advisor Warrant (Park Avenue Capital Group Corp.) — $7.00 | $1.80 | $226.5M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| Finder Warrant — $10.00 | $1.80 | $226.5M | S-1, Nov 10, 2025Dilution tabAs of Nov 1, 2026 | ||||||||
| Lower Bridge Warrants — $11.50 | $1.80 | $226.5M | S-1, Nov 10, 2025Dilution tabAs of Nov 1, 2026 | ||||||||
| PIPE Half Warrants — $12.00 | $1.80 | $226.5M | S-1, Nov 10, 2025Dilution tabAs of Nov 1, 2026 | ||||||||
| PIPE Quarter Warrants — $16.00 | $1.80 | $226.5M | S-1, Nov 10, 2025Dilution tabAs of Nov 1, 2026 | ||||||||
| Upper Bridge Warrants — $15.00 | $1.80 | $226.5M | S-1, Nov 10, 2025Dilution tabAs of Nov 1, 2026 | ||||||||
| June 2025 Pre-Funded Warrants ($0.00001) | $1.00 | $216.8M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 8, 2026 | ||||||||
| Pre-funded warrants (all series) outstanding at September 30, 2026 | $14.41 | $216.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| August 2025 Private Placement Purchase Warrants ($5.50) | $3.35 | $216.0M | 10-Q, Oct 29, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Common stock warrants outstanding (69,778 shares; attributed by arithmetic to the remainder of the April 2024 underwriter Commission Warrant) | $1.38 | $215.8M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| November 2024 RDO Common Warrant – Broadwood Partners (January 2025 closing) | $0.8301 | $214.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| November 2024 RDO Common Warrants – unaffiliated institutional investors (first closing) | $0.8301 | $214.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| November 2024 RDO Placement Agent Warrants – H.C. Wainwright (first closing) | $0.8301 | $214.3M | 424B5, Nov 21, 2024Dilution tabAs of Nov 17, 2026 | ||||||||
| November 2024 RDO Placement Agent Warrants – H.C. Wainwright (January 2025 closing) | $0.8301 | $214.3M | 424B5, Nov 21, 2024Dilution tabAs of Nov 17, 2026 | ||||||||
| July 2022 Warrants (2022 Warrants, non-brokered private placement) | $1.97 | $212.5M | 6-K EX-99.1, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| March 2024 Warrants (bought deal unit warrants, 2024 Warrant Indenture) | $1.97 | $212.5M | 6-K EX-99.1, Nov 16, 2026Dilution tabAs of Nov 17, 2026 |
CAMPCAMP4 Therapeutics Corporation$3.97Last price
2025 Pre-Funded Warrants (Private Placement Initial Closing, September 11, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$249.1M
CAMPCAMP4 Therapeutics Corporation$3.97Last price
2026 Pre-Funded Warrants (Private Placement Second Closing, August 3, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$249.1M
ALTIAlTi Global, Inc.$1.55Last price
Allianz Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$243.3M
ALTIAlTi Global, Inc.$1.55Last price
Constellation Warrants – Additional Tranche (May 15, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$243.3M
ALTIAlTi Global, Inc.$1.55Last price
Constellation Warrants – Initial Tranche (March 27, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$243.3M
CGCCanopy Growth Corporation$0.5361Last price
Acreage replacement warrants (December 2024 Acreage Acquisition)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$241.4M
CGCCanopy Growth Corporation$0.5361Last price
January 2024 Series A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$241.4M
CGCCanopy Growth Corporation$0.5361Last price
January 2024 Series B Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$241.4M
CGCCanopy Growth Corporation$0.5361Last price
January 2026 Investor Warrants (MMCAP exchange)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$241.4M
CGCCanopy Growth Corporation$0.5361Last price
Loan Warrants (January 2026, JGB term loan)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$241.4M
CGCCanopy Growth Corporation$0.5361Last price
May 2024 Investor Warrants (MMCAP)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$241.4M
CGCCanopy Growth Corporation$0.5361Last price
MTL Replacement Warrants (March 2026 MTL acquisition)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$241.4M
CGCCanopy Growth Corporation$0.5361Last price
Put Warrants (Acreage put liability, December 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$241.4M
CGCCanopy Growth Corporation$0.5361Last price
September 2023 Warrants (private placement units)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$241.4M
NNDMNano Dimension Ltd.$1.21Last price
Series B warrants issued to Stern YOI Ltd. Partnership (August 2020)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$240.3M
NNDMNano Dimension Ltd.$1.21Last price
Warrants issued to former director Yaron Eitan (September 2020)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$240.3M
ORBSEightco Holdings Inc.$0.6229Last price
Placement Agent Warrants (September 2025 PIPE, R.F. Lafferty)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$239.2M
ORBSEightco Holdings Inc.$0.6229Last price
Strategic Advisor Warrants (Worldcoin Tower Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$239.2M
ATERAterian, Inc.$0.9481Last price
March 2022 private placement common stock warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$235.7M
ATERAterian, Inc.$0.9481Last price
MidCap Warrant (Credit and Security Agreement, December 22, 2021)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$235.7M
ATERAterian, Inc.$0.9481Last price
Warrants beneficially owned by Armistice Capital Master Fund Ltd. (series not identified)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$235.7M
AZA2Z Cust2Mate Solutions Corp.$5.27Last price
Underwriter warrants – January 2025 underwritten public offering ($8.00, expiring January 29, 2030)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$235.3M
AZA2Z Cust2Mate Solutions Corp.$5.27Last price
Underwriter warrants – September 2025 underwritten public offering ($10.00, expiring September 16, 2030)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$235.3M
ARQQArqit Quantum Inc. Ordinary Shares$12.53Last price
February 2023 Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$234.1M
ARQQArqit Quantum Inc. Ordinary Shares$12.53Last price
February 2023 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$234.1M
ARQQArqit Quantum Inc. Ordinary Shares$12.53Last price
September 2023 Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$234.1M
ARQQArqit Quantum Inc. Ordinary Shares$12.53Last price
September 2023 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$234.1M
OPTXSyntec Optics Holdings, Inc.$5.72Last price
Common Stock Warrants (OmniLit public warrants OPTXW and private placement warrants assumed in the Merger), $11.50 exercise price
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$231.0M
KDKKodiak AI, Inc. Common Stock$1.11Last price
2025 PIPE Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$230.6M
KDKKodiak AI, Inc. Common Stock$1.11Last price
2026 PIPE Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$230.6M
KDKKodiak AI, Inc. Common Stock$1.11Last price
Assumed Kodiak Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$230.6M
KDKKodiak AI, Inc. Common Stock$1.11Last price
NRA Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$230.6M
KDKKodiak AI, Inc. Common Stock$1.11Last price
Private Placement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$230.6M
KDKKodiak AI, Inc. Common Stock$1.11Last price
Public Warrants (KDKRW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$230.6M
NKLRTerra Innovatum Global N.V. Ordinary shares$1.80Last price
Advisor Warrant (Park Avenue Capital Group Corp.) — $7.00
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$226.5M
NKLRTerra Innovatum Global N.V. Ordinary shares$1.80Last price
Finder Warrant — $10.00
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$226.5M
NKLRTerra Innovatum Global N.V. Ordinary shares$1.80Last price
Lower Bridge Warrants — $11.50
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$226.5M
NKLRTerra Innovatum Global N.V. Ordinary shares$1.80Last price
PIPE Half Warrants — $12.00
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$226.5M
NKLRTerra Innovatum Global N.V. Ordinary shares$1.80Last price
PIPE Quarter Warrants — $16.00
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$226.5M
NKLRTerra Innovatum Global N.V. Ordinary shares$1.80Last price
Upper Bridge Warrants — $15.00
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$226.5M
CABACabaletta Bio, Inc.$1.00Last price
June 2025 Pre-Funded Warrants ($0.00001)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$216.8M
YARWYarrow Bioscience Inc$14.41Last price
Pre-funded warrants (all series) outstanding at September 30, 2026
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$216.5M
IMRXImmuneering Corporation$3.35Last price
August 2025 Private Placement Purchase Warrants ($5.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$216.0M
ASPIASP Isotopes Inc. Common Stock$1.38Last price
Common stock warrants outstanding (69,778 shares; attributed by arithmetic to the remainder of the April 2024 underwriter Commission Warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$215.8M
LCTXLineage Cell Therapeutics, Inc.$0.8301Last price
November 2024 RDO Common Warrant – Broadwood Partners (January 2025 closing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$214.3M
LCTXLineage Cell Therapeutics, Inc.$0.8301Last price
November 2024 RDO Common Warrants – unaffiliated institutional investors (first closing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$214.3M
LCTXLineage Cell Therapeutics, Inc.$0.8301Last price
November 2024 RDO Placement Agent Warrants – H.C. Wainwright (first closing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$214.3M
LCTXLineage Cell Therapeutics, Inc.$0.8301Last price
November 2024 RDO Placement Agent Warrants – H.C. Wainwright (January 2025 closing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$214.3M
NGENNervGen Pharma Corp. Common stock$1.97Last price
July 2022 Warrants (2022 Warrants, non-brokered private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$212.5M
NGENNervGen Pharma Corp. Common stock$1.97Last price
March 2024 Warrants (bought deal unit warrants, 2024 Warrant Indenture)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$212.5M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,056 dilution snapshots. 4,860 of 5,316 series state an exercise price and 3,372 an expiry date. 58 record when exercise begins; that count grows as companies are re-extracted. 622 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.